Skip to NavigationSkip to content

News

Europe has seen its first and only approval of a long-acting therapy for opioid dependence, as the European Commission (EC) confirms the marketing...
Indian pharma firm Sun Pharma has announced it is to combine its New Jersey manufacturing operations in a bid to “improve cost efficiencies, it has...
New findings released by analytics firm GlobalData indicates that the market for opioid use disorder therapies is set to grow to reach $4.8 billion...
Novo Nordisk has revealed new Phase 3a data for its investigational GLP-1 analogue therapy semaglutide, showing that the drug met its primary...
Mundipharma has revealed that Pelmeg, its biosimilar version of Amgen’s Neulasta (pegfilgrastim), has been awarded marketing approval by the...
Check out this week's top ten most popular stories on Pharmafile.com!
Novartis' one-time gene therapy Luxturna has been awarded approval by the European Commission for the treatment of vision loss due to a genetic...
The owner of Guernsey-based biotech Immuno Biotech Ltd, David Noakes, will be sentenced this week after admitting to a number of charges concerning...
Young people between the ages of 11 and 19, living with a mental disorder, were more likely to use social media every day in comparison to those of...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches